Table 1. Propensity score matching results, all factors were significantly different between the 2 cohorts prior to matching (p<0.0001).
Before Matching | After Matching | ||||||||||
Codes | Demographics | Mean +/-SD | Patients | % of Cohorts | p-Value | Std Dev | Mean +/- SD | Patients | % of Cohorts | p-Value | Std Dev |
AI | Age at Index | 43.3 +/- 22.4 | 2,814,377 | 100% | <0.0001 | 0.3959 | 52.5 +/- 24.6 52.6 +/- 24.6 | 37,377 | 100% | 0.7967 | 0.0019 |
2186–5 | Not Hispanic or Latino | 1,768,612 | 62.842% | <0.0001 | 0.5406 | 32,085 | 85.842% | 0.4833 | 0.0051 | ||
2106–3 | White | 1,787,611 | 63.517% | <0.0001 | 0.3104 | 29,037 | 77.687% | 0.5508 | 0.0044 | ||
F | Female | 1,552,735 | 55.172% | <0.0001 | 0.0579 | 21,696 | 58.046% | 0.9882 | 0.0001 | ||
M | Male | 1,235,524 | 43.9% | <0.0001 | 0.0398 | 15,666 | 41.913% | 0.9645 | 0.0003 | ||
2054–5 | Black or African American | 379,423 | 13.42% | <0.0001 | 0.0671 | 4,204 | 11.248% | 0.9079 | 0.0008 | ||
UN | Unknown Ethnicity | 776,781 | 27.6% | <0.0001 | 0.5173 | 3,114 | 3.331% | 0.8635 | 0.0013 | ||
2131–1 | Unknown Race | 579,997 | 20.608% | <0.0001 | 0.3614 | 3,054 | 8.171% | 0.8516 | 0.0014 | ||
2135–2 | Hispanic or Latino | 268,984 | 9.557% | <0.0001 | 0.1343 | 2,178 | 5.827% | 0.4019 | 0.0061 | ||
2028–9 | Asian | 49,119 | 1.745% | <0.0001 | 0.0229 | 736 | 1.969% | 0.3902 | 0.0063 | ||
1002–5 | American Indian or Alaska Native | 12,626 | 0.449% | <0.0001 | 0.0216 | 209 | 0.559% | 0.4137 | 0.006 | ||
2076–8 | Native Hawaiian or Other Pacific Islander | 5,601 | 0.199% | <0.0001 | 0.0406 | 137 | 0.367% | 0.2001 | 0.0094 | ||
Codes | Diagnoses | Mean +/-SD | Patients | Percent of Cohorts | p-Value | Std Dev | Mean +/- SD | Patients | % of Cohorts | p-Value | Std Dev |
Z00-Z99 | Factors Influencing Health Status & Contact with Health Services | 1,231,075 | 43.742% | <0.0001 | 1.5668 | 37,146 | 99.382% | 1.0000 | <0.0001 | ||
M00-M99 | Musculoskeletal Disease | 691,394 | 24.567% | <0.0001 | 0.7643 | 22,382 | 59.882% | 0.8814 | 0.0011 | ||
I10-I16 | Hypertension | 467,590 | 16.614% | <0.0001 | 0.6953 | 17,679 | 47.299% | 0.8547 | 0.0013 | ||
E08-E13 | Diabetes Mellitus | 206,563 | 7.34% | <0.0001 | 0.4318 | 8,348 | 22.335% | 0.972 | 0.0003 | ||
E65-E68 | Overweight/Obesity | 185,395 | 6.587% | <0.0001 | 0.3507 | 6,619 | 17.709% | 0.4675 | 0.0053 | ||
I25 | Heart Disease | 122,995 | 4.37% | <0.0001 | 0.3511 | 5,350 | 14.314% | 0.5387 | 0.0045 | ||
I50 | Heart Failure | 81,330 | 2.89% | <0.0001 | 0.3056 | 3,849 | 10.298% | 0.5891 | 0.0040 | ||
J44 | COPD | 72,204 | 2.566% | <0.0001 | 0.2970 | 3,539 | 9.468% | 0.5922 | 0.0039 |
Following matching, there were no significant differences between factors (p>0.05). (Black font = No Influenza Vaccine Cohort, Blue Font = Influenza Vaccine Cohort).